Catalyst Wire Dossier Catalyst Wire Dossier

Reduxium

· Ogevity Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Reduxium, covering 2022-05-27 to 2022-05-27. Get the full timeline:

Most recent: Clinical Trial Update: Immune Responses With Reduxium [NA]

See pricing